Shear-Activated Nanoparticle Aggregates Combined With Temporary Endovascular Bypass to Treat Large Vessel Occlusion
Author(s) -
Miklós Marosföi,
Netanel Korin,
Matthew J. Gounis,
Oktay Uzun,
Srinivasan Vedantham,
Erin Langan,
AnneLaure Papa,
Olivia W. Brooks,
Chris Johnson,
Ajit S Puri,
Deen Bhatta,
Mathumai Kanapathipillai,
Ben R. Bronstein,
Ju-Yu Chueh,
Donald E. Ingber,
Ajay K. Wakhloo
Publication year - 2015
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.115.011063
Subject(s) - medicine , odds ratio , confidence interval , occlusion , cardiology , urology , surgery , anesthesia
The goal of this study is to combine temporary endovascular bypass (TEB) with a novel shear-activated nanotherapeutic (SA-NT) that releases recombinant tissue-type plasminogen activator (r-tPA) when exposed to high levels of hemodynamic stress and to determine if this approach can be used to concentrate r-tPA at occlusion sites based on high shear stresses created by stent placement.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom